Management of aggressive fibromatosis (Review)
- Authors:
- Zhijun Zhang
- Jian Shi
- Tao Yang
- Tongjun Liu
- Kai Zhang
-
Affiliations: Department of Colorectal and Anal Surgery, The Second Hospital of Jilin University, Changchun, Jilin 130012, P.R. China - Published online on: November 17, 2020 https://doi.org/10.3892/ol.2020.12304
- Article Number: 43
-
Copyright: © Zhang et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
This article is mentioned in:
Abstract
Kofoed H, Kamby C and Anagnostaki L: Aggressive fibromatosis. Surg Gynecol Obstet. 160:124–127. 1985.PubMed/NCBI | |
Rock MG, Pritchard DJ, Reiman HM, Soule EH and Brewster RC: Extra-abdominal desmoid tumors. J Bone Joint Surg Am Vol. 66:1369–1374. 1984. View Article : Google Scholar | |
Michael J, Kaplan, Britt-Marie, Ljung, Enzinger FM and Weiss SW: Soft Tissue Tumors (1983) C.V. Mosby Co., St Louis. American Journal of Otolaryngology. 1985. | |
Mackenzie HD: The fibromatoses: A clinicopathological concept. Br Med J. 4:277–281. 1972. View Article : Google Scholar : PubMed/NCBI | |
Musgrove JE and Mcdonald JR: Extra-abdominal desmoid tumors; their differential diagnosis and treatment. Arch Pathol (Chic). 45:513–540. 1948.PubMed/NCBI | |
Li Destri G, Ferraro MJ, Calabrini M, Pennisi M and Magro G: Desmoid-type fibromatosis of the mesentery: Report of a sporadic case with emphasis on differential diagnostic problems. Case Rep Med. 2014:850180. 2014. View Article : Google Scholar : PubMed/NCBI | |
Martínez Trufero J, Pajares Bernad I, Torres Ramón I, Hernando Cubero J and Pazo Cid R: Desmoid-type fibromatosis: Who, when, and how to treat. Curr Treat Options Oncol. 18:292017. View Article : Google Scholar : PubMed/NCBI | |
Escobar C, Munker R, Thomas JO, Li BD and Burton GV: Update on desmoid tumors. Ann Oncol. 23:562–569. 2012. View Article : Google Scholar : PubMed/NCBI | |
Nieuwenhuis MH, Lefevre JH, Bülow S, Järvinen H, Bertario L, Kernéis S, Parc Y and Vasen HF: Family history, surgery, and APC mutation are risk factors for desmoid tumors in familial adenomatous polyposis: An international cohort study. Dis Colon Rectum. 54:1229–1234. 2011. View Article : Google Scholar : PubMed/NCBI | |
Amary MF, Pauwels P, Meulemans E, Roemen GM, Islam L, Idowu B, Bousdras K, Diss TC, O'Donnell P and Flanagan AM: Detection of beta-catenin mutations in paraffin-embedded sporadic desmoid-type fibromatosis by mutation-specific restriction enzyme digestion (MSRED): An ancillary diagnostic tool. Am J Surg Pathol. 31:1299–1309. 2007. View Article : Google Scholar : PubMed/NCBI | |
Rhim JH, Kim JH, Moon KC, Park SW, Sohn CH, Choi SH, Yun TJ and Chang KH: Desmoid-type fibromatosis in the head and neck: CT and MR imaging characteristics. Neuroradiology. 55:351–359. 2013. View Article : Google Scholar : PubMed/NCBI | |
Murphey MD, Ruble CM, Tyszko SM, Zbojniewicz AM, Potter BK and Miettinen M: From the archives of the AFIP: Musculoskeletal fibromatoses: Radiologic-pathologic correlation. Radiographics. 29:2143–2173. 2009. View Article : Google Scholar : PubMed/NCBI | |
Sinha A, Hansmann A, Bhandari S, Gupta A, Burling D, Rana S, Phillips RK, Clark SK and Goh V: Imaging assessment of desmoid tumours in familial adenomatous polyposis: Is state-of-the-art 1.5 T MRI better than 64-MDCT? Br J Radiol. 85:e254–e261. 2012. View Article : Google Scholar : PubMed/NCBI | |
Dinauer PA, Brixey CJ, Moncur JT, Fanburg-Smith JC and Murphey MD: Pathologic and MR imaging features of benign fibrous soft-tissue tumors in adults. Radiographics. 27:173–187. 2007. View Article : Google Scholar : PubMed/NCBI | |
Robbin MR, Murphey MD, Temple HT, Kransdorf MJ and Choi JJ: Imaging of musculoskeletal fibromatosis. Radiographics. 21:585–600. 2001. View Article : Google Scholar : PubMed/NCBI | |
Salas S, Dufresne A, Bui B, Blay JY, Terrier P, Ranchere-Vince D, Bonvalot S, Stoeckle E, Guillou L, Le Cesne A, et al: Prognostic factors influencing Progression-free survival determined from a series of sporadic desmoid tumors: A Wait-and-See policy according to tumor presentation. J Clin Oncol. 29:3553–3558. 2011. View Article : Google Scholar : PubMed/NCBI | |
Gari MK, Guraya SY, Hussein AM and Hego MM: Giant mesenteric fibromatosis: Report of a case and review of the literature. World J Gastrointest Surg. 4:79–82. 2012. View Article : Google Scholar : PubMed/NCBI | |
Ogawa T: Complete resection of a rectus abdominis muscle invaded by desmoid tumors and subsequent management with an abdominal binder: A case report. J Med Case Reps. 12:292018. View Article : Google Scholar | |
Okamura S, Kitahara T, Tamai K, Minoji T, Takabatake H, Watanabe N, Yamamura N, Fukuchi N, Ebisui C, Yokouchi H, et al: Resection of a desmoid tumor originating from the greater omentum after surgery for colon cancer and liver metastasis-a case report. Gan To Kagaku Ryoho. 45:2444–2446. 2018.(In Japanese). PubMed/NCBI | |
Howard JH and Pollock RE: Intra-abdominal and abdominal wall desmoid fibromatosis. Oncol Ther. 4:57–72. 2016. View Article : Google Scholar : PubMed/NCBI | |
Peng PD, Hyder O, Mavros MN, Turley R, Groeschl R, Firoozmand A, Lidsky M, Herman JM, Choti M, Ahuja N, et al: Management and recurrence patterns of desmoids tumors: A Multi-institutional analysis of 211 patients. Ann Surg Oncol. 19:4036–4042. 2012. View Article : Google Scholar : PubMed/NCBI | |
Tsagozis P, Stevenson JD, Grimer R and Carter S: Outcome of surgery for primary and recurrent desmoid-type fibromatosis. A retrospective case series of 174 patients. Ann Med Surg (Lond). 7:14–19. 2017. View Article : Google Scholar | |
Janssen ML, Van Broekhoven DL, Cates JM, Bramer WM, Nuyttens JJ, Gronchi A, Salas S, Bonvalot S, Grünhagen DJ and Verhoef C: Meta-analysis of the influence of surgical margin and adjuvant radiotherapy on local recurrence after resection of sporadic desmoid-type fibromatosis. Br J Surg. 104:347–357. 2017. View Article : Google Scholar : PubMed/NCBI | |
Kujak JL, Liu PT, Johnson GB and Callstrom MR: Early experience with percutaneous cryoablation of extra-abdominal desmoid tumors. Skeletal Radiol. 39:175–182. 2010. View Article : Google Scholar : PubMed/NCBI | |
Leithner A, Gapp M, Leithner K, Radl R, Krippl P, Beham A and Windhager R: Margins in extra-abdominal desmoid tumors: A comparative analysis. J Surg Oncol. 86:152–156. 2004. View Article : Google Scholar : PubMed/NCBI | |
Smith K, Desai J, Lazarakis S and Gyorki D: Systematic review of clinical outcomes following various treatment options for patients with extraabdominal desmoid tumors. Ann Surg Oncol. 25:1544–1554. 2018. View Article : Google Scholar : PubMed/NCBI | |
Lev D, Kotilingam D, Wei C, Ballo MT, Zagars GK, Pisters PW, Lazar AA, Patel SR, Benjamin RS and Pollock RE: Optimizing treatment of desmoid tumors. J Clin Oncol. 25:1785–1791. 2007. View Article : Google Scholar : PubMed/NCBI | |
Gronchi A, Casali PG, Mariani L, Lo Vullo S, Colecchia M, Lozza L, Bertulli R, Fiore M, Olmi P, Santinami M and Rosai J: Quality of surgery and outcome in extra-abdominal aggressive fibromatosis: A series of patients surgically treated at a single institution. J Clin Oncol. 21:1390–1397. 2003. View Article : Google Scholar : PubMed/NCBI | |
Merchant NB, Lewis JJ, Woodruff JM, Leung DHY and Brennan MF: Extremity and trunk desmoid tumors: A multifactorial analysis of outcome. Cancer. 86:2045–2052. 1999. View Article : Google Scholar : PubMed/NCBI | |
Ballo MT, Zagars GK, Pollack A, Pisters PWT and Pollock RA: Desmoid tumor: Prognostic factors and outcome after surgery, radiation therapy, or combined surgery and radiation therapy. J Clin Oncol. 17:158–167. 1999. View Article : Google Scholar : PubMed/NCBI | |
Gronchi A, Le Péchoux C, Dei Tos AP, Le Cesne A, Marrari A, Penel N, Grignani G, Blay JY, Casali PG, Stoeckle E, et al: Sporadic desmoid-type fibromatosis: A stepwise approach to a non-metastasising neoplasm-A position paper from the Italian and the French Sarcoma Group. Ann Oncol. 25:578–583. 2014. View Article : Google Scholar : PubMed/NCBI | |
Cobianchi L, Ravetta V, Viera FT, Filisetti C, Siri B, Segalini E, Maestri M, Dominioni T, Alessiani M, Rossi S and Dionigi P: The challenge of extraabdominal desmoid tumour management in patients with Gardner's syndrome: Radiofrequency ablation, a promising option. World J Surg Oncol. 12:3612014. View Article : Google Scholar : PubMed/NCBI | |
Tremblay KR, Lea WB, Neilson JC, King DM and Tutton SM: Percutaneous cryoablation for the treatment of extra-abdominal desmoid tumors. J Surg Oncol. 120:366–375. 2019. View Article : Google Scholar : PubMed/NCBI | |
Knudsen AL and Bülow S: Desmoid tumour in familial adenomatous polyposis. A review of literature. Fam Cancer. 1:111–119. 2001. View Article : Google Scholar : PubMed/NCBI | |
Eastley N, McCulloch T, Esler C, Hennig I, Fairbairn J, Gronchi A and Ashford R: Extra-abdominal desmoid fibromatosis: A review of management, current guidance and unanswered questions. Eur J Surg Oncol. 42:1071–1083. 2016. View Article : Google Scholar : PubMed/NCBI | |
Colombo C, Miceli R, Le Péchoux C, Palassini E, Honoré C, Stacchiotti S, Mir O, Casali PG, Dômont J, Fiore M, et al: Sporadic extra abdominal wall desmoid-type fibromatosis: Surgical resection can be safely limited to a minority of patients. Eur J Cancer. 51:186–192. 2015. View Article : Google Scholar : PubMed/NCBI | |
Bonvalot S, Ternès N, Fiore M, Bitsakou G, Colombo C, Honoré C, Marrari A, Le Cesne A, Perrone F, Dunant A and Gronchi A: Spontaneous regression of primary abdominal wall desmoid tumors: More common than previously thought. Ann Surg Oncol. 20:4096–4102. 2013. View Article : Google Scholar : PubMed/NCBI | |
Bonvalot S, Eldweny H, Haddad V, Rimareix F, Missenard G, Oberlin O, Vanel D, Terrier P, Blay JY, Le Cesne A and Le Péchoux C: Extra-abdominal primary fibromatosis: Aggressive management could be avoided in a subgroup of patients. Eur J Surg Oncol. 34:462–468. 2008. View Article : Google Scholar : PubMed/NCBI | |
Cho JY, Gupta S, Cho HS, Park MS, Mok SJ, Han I and Kim HS: Role of nonsteroidal anti-inflammatory drug in treatment of extra-abdominal desmoid tumors. Clin Orthop Surg. 10:225–233. 2018. View Article : Google Scholar : PubMed/NCBI | |
Zhao J, Wang Q, Li X, Hu X and Shen H: Effective high intensity focused ultrasound treatment in recurrent aggressive breast fibromatosis: A case report. Onco Targets Ther. 12:5251–5256. 2019. View Article : Google Scholar : PubMed/NCBI | |
De Bree E, Zoras O, Hunt JL, Takes RP, Suárez C, Mendenhall WM, Hinni ML, Rodrigo JP, Shaha AR, Rinaldo A, et al: Desmoid tumors of the head and neck: A therapeutic challenge. Head Neck. 36:1517–1526. 2014.PubMed/NCBI | |
Briand S, Barbier O, Biau D, Bertrand-Vasseur A and Gouin F: Wait-and-See policy as a First-line management for extra-abdominal desmoid tumors. J Bone Joint Surg Am. 96:631–638. 2014. View Article : Google Scholar : PubMed/NCBI | |
Kamath SS, Parsons JT, Marcus RB, Zlotecki RA and Scarborough MT: Radiotherapy for local control of aggressive fibromatosis. Int J Radiat Oncol Biol Phys. 36:325–328. 1996. View Article : Google Scholar : PubMed/NCBI | |
Goy BW, Lee SP, Eilber F, Dorey F, Eckardt J, Fu YS, Juillard GJ and Selch MT: The role of adjuvant radiotherapy in the treatment of resectable desmoid tumors. Int J Radiat Oncol Biol Phys. 39:659–665. 1997. View Article : Google Scholar : PubMed/NCBI | |
Boland PJ, Leung DH, Woodruff JM and Brennan MF: The enigma of desmoid tumors. Ann Surg. 229:866–873. 1999. View Article : Google Scholar : PubMed/NCBI | |
Guadagnolo BA, Zagars GK and Ballo MT: Long-term outcomes for desmoid tumors treated with radiation therapy. Int J Radiat Oncol Biol Phys. 71:441–447. 2008. View Article : Google Scholar : PubMed/NCBI | |
Bishop AJ, Zarzour MA, Ratan R, Torres KE, Feig BW, Wang WL, Lazar AJ, Moon BS, Roland CL and Guadagnolo BA: Long-Term outcomes for patients with desmoid fibromatosis treated with radiation therapy: A 10-Year Update and Re-evaluation of the role of radiation therapy for younger patients. Int J Radiat Oncol Biol Phys. 103:1167–1174. 2019. View Article : Google Scholar : PubMed/NCBI | |
Chen Y, Chen Y and Liu Y: Abnormal presentation of aggressive fibromatosis after radiotherapy for keloids case report and brief literature review. Ann Plast Surg. 83:104–107. 2019. View Article : Google Scholar : PubMed/NCBI | |
Nuyttens JJ, Rust PF, Thomas CR Jr and Turrisi AT III: Surgery versus radiation therapy for patients with aggressive fibromatosis or desmoid tumors: A comparative review of 22 articles. Cancer. 88:1517–1523. 2000. View Article : Google Scholar : PubMed/NCBI | |
Pritchard DJ, Nascimento AG and Petersen IA: Local control of extra-abdominal desmoid tumors. J Bone Joint Surg Am. 78:848–854. 1996. View Article : Google Scholar : PubMed/NCBI | |
Constantinidou A, Jones RL, Scurr M, Al-Muderis O and Judson I: Advanced aggressive fibromatosis: Effective palliation with chemotherapy. Acta Oncologica. 50:455–461. 2011. View Article : Google Scholar : PubMed/NCBI | |
Sze H and Yeung MW: Fibromatosis of the neck causing airway obstruction managed effectively with weekly low-dose methotrexate and vinblastine. Hong Kong Med J. 15:221–223. 2009.PubMed/NCBI | |
Chaudhary P: Mesenteric fibromatosis. Int J Colorectal Dis. 29:1445–1451. 2014. View Article : Google Scholar : PubMed/NCBI | |
Skapek SX, Hawk BJ, Hoffer FA, Dahl GV, Granowetter L, Gebhardt MC, Ferguson WS and Grier HE: Combination chemotherapy using vinblastine and methotrexate for the treatment of progressive desmoid tumor in children. J Clin Oncol. 16:3021–3027. 1998. View Article : Google Scholar : PubMed/NCBI | |
Janinis J, Patriki M, Vini L, Aravantinos G and Whelan JS: The pharmacological treatment of aggressive fibromatosis: A systematic review. Ann Oncol. 14:181–190. 2003. View Article : Google Scholar : PubMed/NCBI | |
Kasper B: Systemic treatment approaches for sporadic desmoid-type fibromatosis: Scarce evidence and recommendations. Oncol Res Treat. 38:244–248. 2015. View Article : Google Scholar : PubMed/NCBI | |
Penel N, Le Cesne AL, Bonvalot S, Giraud A, Bompas E, Rios M, Salas S, Isambert N, Boudou-Rouquette P, Honore C, et al: Surgical versus non-surgical approach in primary desmoid-type fibromatosis patients: A nationwide prospective cohort from the French Sarcoma Group. Eur J Cancer. 83:125–131. 2017. View Article : Google Scholar : PubMed/NCBI | |
Kasper B, Gruenwald V, Reichardt P, Bauer S, Rauch G, Limprecht R, Sommer M, Dimitrakopoulou-Strauss A, Pilz L, Haller F and Hohenberger P: Imatinib induces sustained progression arrest in RECIST progressive desmoid tumours: Final results of a phase II study of the German Interdisciplinary Sarcoma Group (GISG). Eur J Cancer. 76:60–67. 2017. View Article : Google Scholar : PubMed/NCBI | |
Penel N, Le Cesne AL, Bui BN, Perol D, Brain EG, Ray-Coquard I, Guillemet C, Chevreau C, Cupissol D, Chabaud S, et al: Imatinib for progressive and recurrent aggressive fibromatosis (desmoid tumors): An FNCLCC/French Sarcoma Group phase II trial with a long-term follow-up. Ann Oncol. 22:452–457. 2011. View Article : Google Scholar : PubMed/NCBI | |
Chugh R, Wathen JK, Patel SR, Maki RG, Meyers PA, Schuetze SM, Priebat DA, Thomas DG, Jacobson JA, Samuels BL, et al: Efficacy of imatinib in aggressive fibromatosis: Results of a phase II multicenter sarcoma alliance for research through collaboration (SARC) trial. Clin Cancer Res. 16:4884–4891. 2010. View Article : Google Scholar : PubMed/NCBI | |
Liu LP, Ho RL, Chen GG and Lai PB: Sorafenib inhibits hypoxia-inducible factor-1α synthesis: Implications for antiangiogenic activity in hepatocellular carcinoma. Clin Cancer Res. 18:5662–5671. 2012. View Article : Google Scholar : PubMed/NCBI | |
Gonçalves A, Monges G, Yang Y, Palmerini F, Dubreuil P, Noguchi T, Jacquemier J, Di Stefano D, Delpero JR, Sobol H and Bertucci F: Response of a KIT-positive Extra-abdominal fibromatosis to imatinib mesylate and KIT genetic analysis. J Natl Cancer Inst. 98:562–563. 2006. View Article : Google Scholar : PubMed/NCBI | |
Kim S, Yazici YD, Calzada G, Wang ZY, Younes MN, Jasser SA, El-Naggar AK and Myers JN: Sorafenib inhibits the angiogenesis and growth of orthotopic anaplastic thyroid carcinoma xenografts in nude mice. Mol Cancer Ther. 6:1785–1792. 2007. View Article : Google Scholar : PubMed/NCBI | |
Liu L, Cao Y, Chen C, Zhang X, McNabola A, Wilkie D, Wilhelm S, Lynch M and Carter C: Sorafenib blocks the RAF/MEK/ERK pathway, inhibits tumor angiogenesis, and induces tumor cell apoptosis in hepatocellular carcinoma model PLC/PRF/5. Cancer Res. 66:11851–11858. 2006. View Article : Google Scholar : PubMed/NCBI | |
Mace J, Biermann JS, Sondak V, McGinn C, Hayes C, Thomas D and Baker L: Response of extraabdominal desmoid tumors to therapy with imatinib mesylate. Cancer. 95:2373–2379. 2002. View Article : Google Scholar : PubMed/NCBI | |
Cho NL, Carothers AM, Rizvi H, Hasson RM, Redston M and Bertagnolli MM: Immunohistochemical and molecular analysis of tyrosine kinase activity in? desmoid tumors. J Surg Res. 173:0–326. 2012. View Article : Google Scholar | |
Skubitz KM, Manivel JC, Clohisy DR and Frolich JW: Response of imatinib-resistant extra-abdominal aggressive fibromatosis to sunitinib: Case report and review of the literature on response to tyrosine kinase inhibitors. Cancer Chemother Pharmacol. 64:635–640. 2009. View Article : Google Scholar : PubMed/NCBI | |
Jo JC, Hong YS, Kim KP, Lee JL, Lee J, Park YS, Kim SY, Ryu JS, Lee JS and Kim TW: A prospective multicenter phase II study of sunitinib in patients with advanced aggressive fibromatosis. Invest New Drugs. 32:369–376. 2014. View Article : Google Scholar : PubMed/NCBI | |
Gounder MM, Lefkowitz RA, Keohan ML, D'Adamo DR, Hameed M, Antonescu CR, Singer S, Stout K, Ahn L and Maki RG: Activity of sorafenib against desmoid Tumor/Deep fibromatosis. Clin Cancer Res. 17:4082–4090. 2011. View Article : Google Scholar : PubMed/NCBI | |
Braggio D, Koller D, Jin F, Siva N, Zewdu A, Lopez G, Batte K, Casadei L, Welliver M, Strohecker AM, et al: Autophagy inhibition overcomes sorafenib resistance in S45F-mutated desmoid tumors. Cancer. 125:2693–2703. 2019.PubMed/NCBI | |
Shimizu K, Hamada S, Sakai T, Koike H, Yoshida M and Nishida Y: Efficacy of low-dose chemotherapy with methotrexate and vinblastine for patients with extra-abdominal desmoid-type fibromatosis: A systematic review. Jpn J Clin Oncol. 50:419–424. 2020. View Article : Google Scholar : PubMed/NCBI | |
Skapek SX, Ferguson WS, Granowetter L, Devidas M, Perez-Atayde AR, Dehner LP, Hoffer FA, Speights R, Gebhardt MC, Dahl GV, et al: Vinblastine and methotrexate for desmoid fibromatosis in children: Results of a pediatric oncology group phase II trial. J Clin Oncol. 25:501–506. 2007. View Article : Google Scholar : PubMed/NCBI | |
Azzarelli A, Gronchi A, Bertulli R, Tesoro JD, Baratti D, Pennacchioli E, Dileo P, Rasponi A, Ferrari A, Pilotti S and Casali PG: Low-dose chemotherapy with methotrexate and vinblastine for patients with advanced aggressive fibromatosis. Cancer. 92:1259–1264. 2001. View Article : Google Scholar : PubMed/NCBI | |
Reich S, Overberg-Schmidt US, Bührer C and Henze G: Low-dose chemotherapy with vinblastine and methotrexate in childhood desmoid tumors. J Clin Oncol. 17:10861999. View Article : Google Scholar : PubMed/NCBI | |
Meazza C, Bisogno G, Gronchi A, Fiore M, Cecchetto G, Alaggio R, Milano GM, Casanova M, Carli M and Ferrari A: Aggressive fibromatosis in children and adolescents: The Italian experience. Cancer. 116:233–240. 2010.PubMed/NCBI | |
Ananth P, Werger A, Voss S, Rodriguez-Galindo C and Janeway KA: Liposomal doxorubicin: Effective treatment for pediatric desmoid fibromatosis. Pediatr Blood Cancer. Dec 1–2017.(Epub ahead of print). doi: 10.1002/pbc.26375. View Article : Google Scholar | |
Weiss AJ, Horowitz S, Lackman RD and Lackmen RD: Therapy of desmoid tumors and fibromatosis using vinorelbine. Am J Clin Oncol. 22:193–195. 1999. View Article : Google Scholar : PubMed/NCBI | |
Gronchi A, Colombo C, Le Péchoux C, Dei Tos AP, Le Cesne A, Marrari A, Penel N, Grignani G, Blay JY, Casali PG, et al: Sporadic desmoid-type fibromatosis: A stepwise approach to a non-metastasising neoplasm-a position paper from the Italian and the French Sarcoma Group. Ann Oncol. 25:578–583. 2014. View Article : Google Scholar : PubMed/NCBI | |
van Dalen EC, Michiels EM, Caron HN and Kremer LC: Different anthracycline derivates for reducing cardiotoxicity in cancer patients. Cochrane Database Syst Rev. 4:CD0050062006. | |
Wehl G, Rossler J, Otten JE, Boehm N, Uhl M, Kontny U and Niemeyer C: Response of progressive fibromatosis to therapy with liposomal doxorubicin. Onkologie. 27:552–556. 2004.PubMed/NCBI | |
Constantinidou A, Jones RL, Scurr M, Al-Muderis O and Judson I: Pegylated liposomal doxorubicin, an effective, well-tolerated treatment for refractory aggressive fibromatosis. Eur J Cancer. 45:2930–2934. 2009. View Article : Google Scholar : PubMed/NCBI | |
Shkalim Zemer V, Toledano H, Kornreich L, Freud E, Atar E, Avigad S, Feinberg-Gorenshtein G, Fichman S, Issakov J, Dujovny T, et al: Sporadic desmoid tumors in the pediatric population: A single center experience and review of the literature. J Pediatr Surg. 52:1637–1641. 2017. View Article : Google Scholar : PubMed/NCBI | |
Ayala AG, Ro JY, Goepfert H, Cangir A, Khorsand J and Flake G: Desmoid fibromatosis: A clinicopathologic study of 25 children. Semin Diagn Pathol. 3:138–150. 1986.PubMed/NCBI | |
Bonvalot S, Rimareix F, Causeret S, Le Péchoux C, Boulet B, Terrier P, Le Cesne A and Muret J: Hyperthermic isolated limb perfusion in locally advanced soft tissue sarcoma and progressive desmoid-type fibromatosis with TNF 1 mg and melphalan (T1-M HILP) is safe and efficient. Ann Surg Oncol. 16:3350–3357. 2009. View Article : Google Scholar : PubMed/NCBI | |
van Broekhoven DL, Deroose JP, Bonvalot S, Gronchi A, Grünhagen DJ, Eggermont AM and Verhoef C: Isolated limb perfusion using tumour necrosis factor α and melphalan in patients with advanced aggressive fibromatosis. Br J Surg. 101:1674–1680. 2014. View Article : Google Scholar : PubMed/NCBI | |
Raney B, Evans A, Granowetter L, Schnaufer L and Littman P: Nonsurgical management of children with recurrent OT unresectable fibromatosis. Pediatrics. 79:394–398. 1987.PubMed/NCBI | |
Weiss AJ and Lackman RD: Low-dose chemotherapy of desmoid tumors. Cancer. 64:1192–1194. 1989. View Article : Google Scholar : PubMed/NCBI | |
Cole NM: Extra-abdominal desmoid tumors. J Bone Joint Surg Br. 53:373–377. 1979. | |
Raney RB J: Chemotherapy for children with aggressive fibromatosis and Langerhans' cell histiocytosis. Clin Orthop Relat Res. 58–63. 1991.PubMed/NCBI | |
Kummar S, O'Sullivan Coyne G, Do KT, Turkbey B, Meltzer PS, Polley E, Choyke PL, Meehan R, Vilimas R, Horneffer Y, et al: Clinical Activity of the γ-Secretase inhibitor PF-03084014 in adults with desmoid tumors (Aggressive Fibromatosis). J Clin Oncol. 35:1561–1569. 2017. View Article : Google Scholar : PubMed/NCBI | |
Agresta L, Kim H, Turpin BK, Nagarajan R, Plemmons A, Szabo S, Dasgupta R, Sorger JI and Pressey JG: Pazopanib therapy for desmoid tumors in adolescent and young adult patients. Pediatr Blood Cancer. 65:e269682018. View Article : Google Scholar : PubMed/NCBI | |
Rombouts SJE, Vogel JA, Van Santvoort HC, van Lienden KP, van Hillegersberg R, Busch OR, Besselink MG and Molenaar IQ: Systematic review of innovative ablative therapies for the treatment of locally advanced pancreatic cancer. Br J Surg. 102:182–193. 2015. View Article : Google Scholar : PubMed/NCBI | |
Zhou Y: High-Intensity focused ultrasound treatment for advanced pancreatic Cancer. Gastroenterol Res Pract. 2014:2053252014. View Article : Google Scholar : PubMed/NCBI | |
Grimaldi MC, Trentin C, Gullo RL and Cassano E: Fibromatosis of the breast mimicking cancer: A case report. Radiol Case Rep. 13:1–5. 2017. View Article : Google Scholar : PubMed/NCBI | |
Haar GT and Coussios C: High intensity focused ultrasound: Past, present and future. Int J Hyperthermia. 23:85–87. 2007. View Article : Google Scholar : PubMed/NCBI | |
Ghanouni P, Dobrotwir A, Bazzocchi A, Bucknor M, Bitton R, Rosenberg J, Telischak K, Busacca M, Ferrari S, Albisinni U, et al: Magnetic resonance-guided focused ultrasound treatment of extra-abdominal desmoid tumors: A retrospective multicenter study. Eur Radiol. 27:732–740. 2017. View Article : Google Scholar : PubMed/NCBI | |
Shi Y, Huang Y, Zhou M, Ying X and Hu X: High-intensity focused ultrasound treatment for intra-abdominal desmoid tumors: A report of four cases. J Med Ultrasonics. 43:279–284. 2016. View Article : Google Scholar | |
Wang Y, Wang W and Tang J: Ultrasound-guided high intensity focused ultrasound treatment for extra-abdominal desmoid tumours: Preliminary results. Int J Hyperthermia. 27:648–653. 2011. View Article : Google Scholar : PubMed/NCBI | |
Zhao WP, Han ZY, Zhang J, Yu XL, Cheng ZG, Zhou X and Liang P: Early experience: High-intensity focused ultrasound treatment for intra-abdominal aggressive fibromatosis of failure in surgery. Br J Radiol. 89:201510262016. View Article : Google Scholar : PubMed/NCBI | |
Kurup AN and Callstrom MR: Image-guided percutaneous ablation of bone and soft tissue tumors. Semin Intervent Radiol. 27:276–284. 2010. View Article : Google Scholar : PubMed/NCBI | |
Kurup AN and Callstrom MR: Expanding role of percutaneous ablative and consolidative treatments for musculoskeletal tumours. Clin Radiol. 72:645–656. 2017. View Article : Google Scholar : PubMed/NCBI | |
Schmitz JJ, Schmit GD, Atwell TD, Callstrom MR, Kurup AN, Weisbrod AJ and Morris JM: Percutaneous cryoablation of extraabdominal desmoid tumors: A 10-year experience. Am J Roentgenol. 207:190–195. 2016. View Article : Google Scholar | |
Havez M, Lippa N, Al-Ammari S, Kind M and Cornelis F: Percutaneous image-guided cryoablation in inoperable extra-abdominal desmoid tumors: A study of tolerability and efficacy. Cardiovasc Intervent Radiol. 37:1500–1506. 2014. View Article : Google Scholar : PubMed/NCBI | |
Baek JH, Lee JH, Jin YS, Bae JI and Na DG: Complications encountered in the treatment of benign thyroid nodules with US-guided radiofrequency ablation: A multicenter study. Radiology. 262:335–342. 2012. View Article : Google Scholar : PubMed/NCBI | |
Kim AH, Ko HK, Won JY and Lee DY: Percutaneous radiofrequency ablation: A novel treatment of facial venous malformation. J Vasc Surg. 50:424–427. 2009. View Article : Google Scholar : PubMed/NCBI | |
Barrow E, Newton K, Rajashanker B, Lee S, Evans DG and Hill J: Successful radiofrequency ablation of an anterior abdominal wall desmoid in familial adenomatous polyposis. Colorectal Dis. 15:e160–e163. 2013. View Article : Google Scholar : PubMed/NCBI | |
Ilaslan H, Schils J, Joyce M, Marks K and Sundaram M: Radiofrequency ablation: Another treatment option for local control of desmoid tumors. Skeletal Radiol. 39:169–173. 2010. View Article : Google Scholar : PubMed/NCBI | |
Tsz-Kan T, Man-Kwong C, Shang-Jen JS, Ying-Lee L, Wai Man-Wah A and Hon-Shing F: Radiofrequency ablation of recurrent fibromatosis. J Vasc Int Radiol. 18:147–150. 2007. View Article : Google Scholar | |
Ko HK and Kang HG: Radiofrequency ablation for the treatment of recurring desmoid tumors after repeated surgical resection: Usefulness of the moving-tip technique. Curr Orthop Pract. 24:547–551. 2013. View Article : Google Scholar | |
Eastley NC, Hennig IM, Esler CP and Ashford RU: Nationwide trends in the current management of desmoid (Aggressive) fibromatosis. Clin Oncol. 27:362–368. 2015. View Article : Google Scholar | |
de Camargo VP, Keohan ML, D'Adamo DR, Antonescu CR, Brennan MF, Singer S, Ahn LS and Maki RG: Clinical outcomes of systemic therapy for patients with deep fibromatosis (desmoid tumor). Cancer. 116:2258–2265. 2010.PubMed/NCBI | |
Tanaka K, Yoshikawa R, Yanagi H, Gega M, Fujiwara Y, Hashimoto-Tamaoki T, Hirota S, Tsujimura T and Tomita N: Regression of sporadic intra-abdominal desmoid tumour following administration of non-steroidal anti-inflammatory drug. World J Surg Oncol. 6:172008. View Article : Google Scholar : PubMed/NCBI | |
Sturt NJH, Phillips RK and Clark SK: High-dose tamoxifen and sulindac as first-line treatment for desmoid tumors. Cancer. 101:6522004. View Article : Google Scholar : PubMed/NCBI | |
Lackner H, Urban C, Kerbl R, Schwinger W and Beham A: Noncytotoxic drug therapy in children with unresectable desmoid tumors. Cancer. 80:334–340. 1997. View Article : Google Scholar : PubMed/NCBI | |
Bocale D, Rotelli MT, Cavallini A and Altomare DF: Anti-oestrogen therapy in the treatment of desmoid tumours: A systematic review. Colorectal Dis. 13:e388–e395. 2011. View Article : Google Scholar : PubMed/NCBI | |
Okuno S: The enigma of desmoid tumors. Curr Treat Options Oncol. 7:438–443. 2006. View Article : Google Scholar : PubMed/NCBI | |
Yaffe K, Krueger K, Sarkar S, Grady D, Barrett-Connor E, Cox DA and Nickelsen T; Multiple Outcomes of Raloxifene Evaluation Investigators, : Cognitive function in postmenopausal women treated with raloxifene. N Engl J Med. 344:1207–1213. 2001. View Article : Google Scholar : PubMed/NCBI | |
Ettinger B, Black DM, Mitlak BH, Knickerbocker RK, Nickelsen T, Genant HK, Christiansen C, Delmas PD, Zanchetta JR, Stakkestad J, et al: Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: Results from a 3-year randomized clinical trial. Multiple Outcomes of Raloxifene Evaluation (MORE) Investigators. JAMA. 282:637–645. 1999. View Article : Google Scholar : PubMed/NCBI | |
Cummings SR, Eckert S, Krueger KA, Grady D, Powles TJ, Cauley JA, Norton L, Nickelsen T, Bjarnason NH, Morrow M, et al: The effect of raloxifene on risk of breast cancer in postmenopausal Women: Results From the MORE randomized trial. Multiple Outcomes of Raloxifene Evaluation. JAMA. 281:2189–2197. 1999. View Article : Google Scholar : PubMed/NCBI | |
Delmas PD, Bjarnason NH, Mitlak BH, Ravoux AC, Shah AS, Huster WJ, Draper M and Christiansen C: Effects of raloxifene on bone mineral density, serum cholesterol concentrations, and uterine endometrium in postmenopausal women. N Engl J Med. 337:1641–1647. 1997. View Article : Google Scholar : PubMed/NCBI | |
Desurmont T, Lefèvre JH, Shields C, Colas C, Tiret E and Parc Y: Desmoid tumour in familial adenomatous polyposis patients: Responses to treatments. Fam Cancer. 14:31–39. 2015. View Article : Google Scholar : PubMed/NCBI | |
Quast DR, Schneider R, Burdzik E, Hoppe S and Möeslein G: Long-term outcome of sporadic and FAP-associated desmoid tumors treated with high-dose selective estrogen receptor modulators and sulindac: A single-center long-term observational study in 134 patients. Fam Cancer. 15:31–40. 2016. View Article : Google Scholar : PubMed/NCBI | |
Bauernhofer T, Stöger H, Schmid M, Smola M, Gürtl-Lackner B, Höfler G, Ranner G, Reisinger E and Samonigg H: Sequential treatment of recurrent mesenteric desmoid tumor. Cancer. 77:1061–1065. 1996. View Article : Google Scholar : PubMed/NCBI | |
Skapek SX, Anderson JR, Hill DA, Henry D, Spunt SL, Meyer W, Kao S, Hoffer FA, Grier HE, Hawkins DS and Raney RB: Safety and efficacy of high-dose tamoxifen and sulindac for desmoid tumor in children: Results of a Children's Oncology Group (COG) phase II study. Pediatr Blood Cancer. 60:1108–1112. 2013. View Article : Google Scholar : PubMed/NCBI | |
Wang Z, Wu J, Tian X and Hao C: Targeted therapy of desmoid-type fibromatosis: Mechanism, current situation, and future prospects. Front Med. 13:427–437. 2019. View Article : Google Scholar : PubMed/NCBI | |
Tsukada K, Church JM, Jagelman DG, Fazio VW, McGannon E, George CR, Schroeder T, Lavery I and Oakley J: Noncytotoxic drug therapy for intra-abdominal desmoid tumor in patients with familial adenomatous polyposis. Dis Colon Rectum. 35:29–33. 1992. View Article : Google Scholar : PubMed/NCBI | |
Huang PW and Tzen CY: Prognostic factors in desmoid-type fibromatosis. Pathology. 42:147–150. 2010. View Article : Google Scholar : PubMed/NCBI | |
Nishida Y, Tsukushi S, Shido Y, Urakawa H, Arai E and Ishiguro N: Transition of treatment for patients with extra-abdominal desmoid tumors: Nagoya University modality. Cancers. 4:88–99. 2012. View Article : Google Scholar : PubMed/NCBI | |
Yang S, Wang X, Jiang H, Wang Y, Li Z and Lu H: Effective treatment of aggressive fibromatosis with celecoxib guided by genetic testing. Cancer Biol Ther. 18:757–760. 2017. View Article : Google Scholar : PubMed/NCBI | |
Wang YC and Wong JU: Complete remission of pancreatic head desmoid tumor treated by COX-2 inhibitor-a case report. World J Surg Oncol. 14:1902016. View Article : Google Scholar : PubMed/NCBI | |
Waddell W: Indomethacin and ascorbate inhibit desmoid tumors. J Surg Oncol. 15:85–90. 2010. View Article : Google Scholar | |
Yildiz F, Kars A, Cengiz M, Yildiz O, Akyürek S, Selek U, Ozyigit G and Atahan IL: 1,25-Dihydroxy vitamin D3: Can it be an effective therapeutic option for aggressive fibromatosis. Med Hypotheses. 64:333–336. 2005. View Article : Google Scholar : PubMed/NCBI | |
Ferah Y, Ayse K, Mustafa C, Ugur S, Murat G and Lale AI: Possible therapeutic role of vitamin D-3 in aggressive fibromatosis. Jpn J Clin Oncol. 34:472–475. 2004. View Article : Google Scholar : PubMed/NCBI | |
Leithner A, Schnack B, Katterschafka T, Wiltschke C, Amann G, Windhager R, Kotz R and Zielinski CC: Treatment of extra-abdominal desmoid tumors with interferon-alpha with or without tretinoin. J Surg Oncol. 73:21–25. 2000. View Article : Google Scholar : PubMed/NCBI | |
Goto T, Nemoto T, Ogura K, Hozumi T and Funata N: Successful treatment of desmoid tumor of the chest wall with tranilast: A case report. J Med Case Rep. 4:3842010. View Article : Google Scholar : PubMed/NCBI | |
Nakada I, Ubukata H, Goto Y, Watanabe Y, Sato S, Tabuchi T and Soma T: Prednisolone therapy for intra-abdominal desmoid tumors in a patient with familial adenomatous polyposis. J Gastroenterol. 32:255–259. 1997. View Article : Google Scholar : PubMed/NCBI | |
Umemoto S, Makuuchi H, Amemiya T, Yamaguchi H, Oka S, Owada T and Koizumi K: Intra-abdominal desmoid tumors in familial polyposis coli: A case report of tumor regression by prednisolone therapy. Dis Colon Rectum. 34:89–93. 1991. View Article : Google Scholar : PubMed/NCBI | |
Waddell WR, Cerner RE and Reich MP: Nonsteroid antiinflammatory drugs and tamoxifen for desmoid tumors and carcinoma of the stomach. J Surg Oncol. 22:197–211. 1983. View Article : Google Scholar : PubMed/NCBI | |
Waddell DWR and Gerner RE: Indomethacin and ascorbate inhibit desmoid tumors. J Surg Oncol. 15:85–90. 1980. View Article : Google Scholar : PubMed/NCBI | |
Crago AM, Denton B, Salas S, Dufresne A, Mezhir JJ, Hameed M, Gonen M, Singer S and Brennan MF: A prognostic nomogram for prediction of recurrence in desmoid fibromatosis. Ann Surg. 258:347–353. 2013. View Article : Google Scholar : PubMed/NCBI | |
Faulkner L: Pediatric desmoid tumor: Retrospective analysis of 63 cases. J Clin Oncol. 13:2813–2818. 1995. View Article : Google Scholar : PubMed/NCBI |